Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A McKinna

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|December 1, 1993
Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancerS R Johnston, B P Haynes, N P Sacks, et al.
Cancer Research|August 1, 1992
Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatmentA Butta, K MacLennan, K C Flanders, et al.
Lancet (London, England)|September 15, 1984
Low-dose aminoglutethimide in treatment of advanced breast cancerR Stuart-Harris, M Dowsett, T Bozek, et al.
Cancer|February 1, 1978
Combination chemotherapy of metastatic breast cancer with vincristine adriamycin and prednisoloneJ A Russell, J W Baker, P J Dady, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1989
Primary medical therapy for operable breast cancerJ L Mansi, I E Smith, G Walsh, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1986
Prognostic significance of micrometastases in bone marrow in patients with primary breast cancerR C Coombes, U Berger, J Mansi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Adjuvant aminoglutethimide for postmenopausal patients with primary breast cancer: analysis at 8 yearsA L Jones, T J Powles, M Law, et al.
Radiology|October 1, 1993
Breast diseases: color Doppler US in differential diagnosisD O Cosgrove, R P Kedar, J C Bamber, et al.
Cancer Letters|May 23, 2001
Contribution of germline MLH1 and MSH2 mutations to lobular carcinoma in situ of the breastJ G Stone, G Coleman, B Gusterson, et al.
British Journal of Cancer|July 1, 1989
A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancerT J Powles, J R Hardy, S E Ashley, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|December 1, 1993
Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancerS R Johnston, B P Haynes, N P Sacks, et al.
Cancer Research|August 1, 1992
Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatmentA Butta, K MacLennan, K C Flanders, et al.
Lancet (London, England)|September 15, 1984
Low-dose aminoglutethimide in treatment of advanced breast cancerR Stuart-Harris, M Dowsett, T Bozek, et al.
Cancer|February 1, 1978
Combination chemotherapy of metastatic breast cancer with vincristine adriamycin and prednisoloneJ A Russell, J W Baker, P J Dady, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1989
Primary medical therapy for operable breast cancerJ L Mansi, I E Smith, G Walsh, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1986
Prognostic significance of micrometastases in bone marrow in patients with primary breast cancerR C Coombes, U Berger, J Mansi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Adjuvant aminoglutethimide for postmenopausal patients with primary breast cancer: analysis at 8 yearsA L Jones, T J Powles, M Law, et al.
Radiology|October 1, 1993
Breast diseases: color Doppler US in differential diagnosisD O Cosgrove, R P Kedar, J C Bamber, et al.
Cancer Letters|May 23, 2001
Contribution of germline MLH1 and MSH2 mutations to lobular carcinoma in situ of the breastJ G Stone, G Coleman, B Gusterson, et al.
British Journal of Cancer|July 1, 1989
A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancerT J Powles, J R Hardy, S E Ashley, et al.
Pageof 5